Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07211607 · ClinicalTrials.gov registry record · Phase 1

I.V. Selonabant in Healthy Adult Subjects

A Phase 1 study of Healthy Volunteers, sponsored by Anebulo Pharmaceuticals.

Recruiting
Registry status
Phase 1
Development phase
40
Enrollment target
1
Study location

NCT07211607: Recruiting Phase 1 study of Healthy Volunteers, sponsored by Anebulo Pharmaceuticals.

NCT07211607 is a Phase 1 study of Healthy Volunteers that is actively recruiting participants, run by Anebulo Pharmaceuticals. The registered enrollment target is 40 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07211607, a Phase 1 study of Healthy Volunteers, is actively recruiting participants, sponsored by Anebulo Pharmaceuticals.

RECRUITING
Registry status
Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous Selonabant in Healthy Adult Subjects Aged 18 to 30 Years

Conditions Studied

Interventions

  • DRUG placebo
  • DRUG selonabant

Study Locations (1)

Texas

  • PPD Austin Clinical Research Unit - Austin

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-22
Est. Completion 2026-08-25
Phase Phase 1

Sponsor

Anebulo Pharmaceuticals

2 total trials

What the Registry Record Tells You About NCT07211607

The ClinicalTrials.gov registry entry for NCT07211607 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (92% lower). The listed sponsor is Anebulo Pharmaceuticals, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT07211607 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07211607 about?

NCT07211607 is a clinical study titled "I.V. Selonabant in Healthy Adult Subjects". This is a Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous Selonabant in Healthy Adult Subjects Aged 18 to 30 Years

What is the current status of trial NCT07211607?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2025-09-22. Estimated completion is 2026-08-25.

What conditions does trial NCT07211607 study?

This clinical trial studies the following conditions: Healthy Volunteers.

What interventions are being tested in trial NCT07211607?

The interventions under investigation include: placebo (DRUG), selonabant (DRUG).

Who is sponsoring clinical trial NCT07211607?

This trial is sponsored by Anebulo Pharmaceuticals, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07211607 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.